Sharescart Research Club logo ×
Screener Research Buy Unlisted Shares Sell Unlisted Shares Startup Funding New IPO New

Nureca Ltd.

₹270 -2.4 | 0.9%

Market Cap ₹270 Cr.

Stock P/E 319.2

P/B 1.4

Current Price ₹270

Book Value ₹ 194.3

Face Value 10

52W High ₹447

Dividend Yield 0%

52W Low ₹ 198

Nureca Ltd. Research see more...

Overview Inc. Year: 2016Industry: Medical Equipment/Supplies/Accessories

Nureca Limited, a B2C agency, engages in the domestic healthcare and well-being products commercial enterprise in India. It gives chronic disease merchandise, inclusive of nebulizers, blood pressure video display units, finger pulse oximeter, glucose meter, and thermometer; orthopaedic products, which includes massagers, ache monitors, posture correctors, and rehabilitation products; and humidifiers and steamers, non-public scales, yoga and exercising, health monitoring, and dental and personal care products. The organisation also provides mother and toddler care products comprising baby feeding, carry cots, infant skincare, and bottle heaters and steamers; nutritional supplements and weight control merchandise; and ECG, health tracker, and smart weighing scale merchandise. Nureca Ltd offers its merchandise underneath Dr Trust, Dr Physio, and Trumom brands. The enterprise sells its products via third party e-trade players, vendors, and retailers; and through its website, drtrust.In. Nureca Ltd was founded in 2016 and is primarily based in Chandigarh, India.

Read More..

Nureca Ltd. Share Price

New

| |

Volume
Price

Quarterly Price

Show Value Show %

Nureca Ltd. Quarterly Results

#(Fig in Cr.) Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 28 21 21 31 22 17 20 31 26 32
Other Income 2 2 3 3 6 -1 6 3 1 2
Total Income 30 23 24 35 28 16 26 34 28 34
Total Expenditure 29 25 24 30 27 21 23 34 30 31
Operating Profit 1 -1 -0 5 2 -6 3 1 -3 3
Interest 0 0 0 0 0 0 0 0 0 1
Depreciation 1 1 1 1 1 1 1 1 1 1
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 0 -2 -1 4 1 -6 3 -0 -3 2
Provision for Tax -0 -0 -0 1 1 -2 1 0 -0 -0
Profit After Tax 0 -2 -1 3 0 -4 2 -0 -3 2
Adjustments 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 0 -2 -1 3 0 -4 2 -0 -3 2
Adjusted Earnings Per Share 0.3 -1.5 -0.7 2.9 0.2 -4.1 1.7 -0.5 -2.8 2.5

Nureca Ltd. Profit & Loss

#(Fig in Cr.) Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 20 62 99 213 256 111 92 110 109
Other Income 0 0 0 3 8 7 11 13 12
Total Income 20 62 99 216 263 118 102 122 122
Total Expenditure 16 53 90 152 200 126 102 117 118
Operating Profit 4 9 10 64 63 -8 0 5 4
Interest 0 0 1 2 1 0 0 1 1
Depreciation 0 0 0 0 1 2 2 2 4
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0
Profit Before Tax 4 9 9 62 61 -11 -3 1 2
Provision for Tax 1 3 2 16 16 -2 -1 0 1
Profit After Tax 3 6 6 46 45 -8 -2 1 1
Adjustments 0 0 0 0 0 0 0 0 0
Profit After Adjustments 3 6 6 46 45 -8 -2 1 1
Adjusted Earnings Per Share 444.6 889.4 913.6 46.4 45 -8.3 -1.8 0.8 0.9

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 20% -25% 2% 0%
Operating Profit CAGR 0% -57% -13% 0%
PAT CAGR 0% -72% -30% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -2% -34% NA% NA%
ROE Average 0% -2% 14% 90%
ROCE Average 1% -2% 19% 74%

Nureca Ltd. Balance Sheet

#(Fig in Cr.) Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 2 8 15 163 203 195 193 194
Minority's Interest 0 0 0 0 0 0 0 0
Borrowings 0 0 9 1 0 0 0 1
Other Non-Current Liabilities 0 0 0 2 4 0 -2 -1
Total Current Liabilities 5 15 10 24 45 9 9 12
Total Liabilities 7 24 34 190 252 204 200 207
Fixed Assets 0 1 1 4 10 9 7 9
Other Non-Current Assets 0 0 0 0 3 9 1 8
Total Current Assets 7 23 33 186 239 187 193 190
Total Assets 7 24 34 190 252 204 200 207

Nureca Ltd. Cash Flow

#(Fig in Cr.) Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 0 0 0 17 8 1 14
Cash Flow from Operating Activities 0 0 -8 35 1 10 -3 -19
Cash Flow from Investing Activities -0 -0 -0 -110 -3 -16 18 8
Cash Flow from Financing Activities -0 -0 8 92 -7 -2 -1 -0
Net Cash Inflow / Outflow 0 0 -0 17 -9 -8 14 -11
Closing Cash & Cash Equivalent 0 0 0 17 8 1 14 3

Nureca Ltd. Ratios

# Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 444.57 889.43 913.57 46.37 44.96 -8.25 -1.79 0.85
CEPS(Rs) 445.43 897.57 967 46.8 46.44 -5.86 0.57 3.18
DPS(Rs) 0 0 0 2 3 0 0 0
Book NAV/Share(Rs) 104.29 993.57 1990.71 163.1 203.2 194.88 193.11 194.29
Core EBITDA Margin(%) 21.82 14.2 9.37 27.36 20.55 -12.87 -10.23 -6.4
EBIT Margin(%) 21.88 14.25 9.07 28.42 22.85 -8.83 -2.06 2.1
Pre Tax Margin(%) 21.56 13.87 8.32 27.71 22.57 -9.21 -2.54 1.1
PAT Margin (%) 15.52 9.77 6.18 20.62 16.64 -7.08 -1.79 0.69
Cash Profit Margin (%) 15.55 9.86 6.55 20.8 17.19 -5.03 0.57 2.61
ROA(%) 44.35 40.78 22.3 41.38 20.33 -3.62 -0.89 0.42
ROE(%) 426.3 162.03 61.23 52.39 24.55 -4.14 -0.92 0.44
ROCE(%) 255.06 179.97 56.7 67.61 33.57 -5.17 -1.06 1.31
Receivable days 30.69 30.18 38.39 10.65 2.11 11.25 10.79 7.39
Inventory Days 64.42 48.92 52.9 43.16 67.53 152.88 119.26 105.87
Payable days 172.97 68.29 44.04 26.74 18.53 23.46 30.6 31.48
PER(x) 0 0 0 12.98 30.3 0 0 248.64
Price/Book(x) 0 0 0 3.69 6.7 1.54 1.32 1.08
Dividend Yield(%) 0 0 0 0.33 0.22 0 0 0
EV/Net Sales(x) -0 0.01 0.1 2.23 5 2.06 2.29 1.52
EV/Core EBITDA(x) -0.01 0.04 1 7.41 20.22 -29.03 685.11 34.01
Net Sales Growth(%) 0 208.7 60.63 114.69 19.72 -56.44 -17.42 19.29
EBIT Growth(%) 0 107.07 3.27 581.55 -3.46 -116.67 80.03 224.43
PAT Growth(%) 0 100.06 2.71 625.16 -3.05 -118.35 78.25 147.16
EPS Growth(%) 0 100.06 2.71 -94.92 -3.05 -118.35 78.25 147.16
Debt/Equity(x) 0 0.06 0.7 0.01 0 0 0 0.01
Current Ratio(x) 1.32 1.5 3.45 7.78 5.28 21 20.77 15.32
Quick Ratio(x) 0.65 0.62 1.72 6.24 3.89 17.12 17.44 12.1
Interest Cover(x) 68.55 37.38 12.14 39.89 83.3 -22.87 -4.2 2.11
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0.01

Nureca Ltd. Shareholding Pattern

# Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Promoter 62.98 62.98 62.98 63.24 63.24 63.24 63.24 63.77 64.06 64.3
FII 0.1 0.1 0.1 0.1 0.07 0.07 0.07 0.69 0.36 1.07
DII 0 0 0 0 0 0 0 0 0 0
Public 36.91 36.91 36.91 36.66 36.69 36.69 36.69 35.53 35.58 34.62
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company is almost debt free.

Cons

  • Company has a low return on equity of -2% over the last 3 years.
  • Debtor days have increased from 30.6 to 31.48days.
  • The company has delivered a poor profit growth of -30% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Nureca Ltd. News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....